Login

Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals 00:00:00

Share On Facebook Share On Twitter

Corporate Profile interviews Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals (RNN)

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Namibians Urged to Explore Geological Survey Museum | Mrs Anna-Karren Nguno - President of Namibia Geological Survey
00:10:00
Exploring Tanzania's Gold Frontier: A Conversation with Dr. Ray Skipper, CEO of Endany Gold Inc.
00:10:00
Unveiling Mexico's FIBRA Macquarie: A Spotlight on Excellence
00:10:00
CEO Alan Trefler positions Pegasystems for the long game in customer-centric innovation and sustainable growth.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
Sandstorm's Strategic Focus: Debt Reduction, Share Buybacks, and Future Growth"
00:10:00
Navigating European High Yield Bonds: Madelaine Jones' Insights on Bloomberg Markets (2022)
00:10:00
Invest Barbados - Investor Tales from Barbados - Jo Edghill | Tyrone Browne, , Barbados (TS)
00:10:00
Tom Barrack on Colony Capital's Strategic Shift and Global Investment Landscape |Tom Barrack, Founder, Colony Capital.
00:10:00
Digital Overload: CEO Urges Embracing Workplace Social Bonds | PATRICE BARBEDETTE, CEO of Easyvista SA
00:10:00
Invests financial & social capital into exceptional ventures led by underrepresented founders|Sean Mendy,Founding Partner,Concrete Rose Capital
00:10:00
Embodied Expressions: Art Reflecting Brazil's Political and Social Turmoil
00:10:00
Farid Basir, Chief Human Capital Officer at Telekom Malaysia, to speak at Asia's largest HR and Work Tech Conference in February.

© 2026 Nehu